Most reconstitution errors happen before the needle even touches the vial. Researchers add the wrong volume, use the wrong diluent, or pull the wrong draw and end up with a concentration that makes every subsequent measurement an exercise in mental arithmetic. Tesamorelin is a 44-amino-acid GHRH analog — a fragile molecule that took Falutz et al. (2007) and Stanley et al. (2014) years to validate in controlled-temperature, precisely-reconstituted research settings. Getting the reconstitution math right is not a minor detail. It is the difference between following the published protocol and running an entirely different experiment.
This guide exists because tesamorelin in stock UAE comes in two vial sizes — 5mg and 10mg — and the correct BAC water volume, resulting concentration, and per-dose draw volume are different for each. REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched tesamorelin across all 7 emirates, and this is the reconstitution reference we recommend every investigator keep bookmarked before they open a vial.
The distinction matters. Sterile water for injection (SWFI) is a single-use diluent: once the vial is punctured, the absence of any antimicrobial agent means microbial contamination risk rises with every subsequent draw. A 5mg tesamorelin vial yields 5-10 separate research draws depending on dosing context — that is 5-10 needle punctures of the septum.
Bacteriostatic water contains 0.9% benzyl alcohol, a bacteriostatic preservative that inhibits microbial growth and extends the practical stability window of a multi-use vial. This is what the Falutz 2007 and Stanley 2014 protocols implicitly assumed when investigators drew from reconstituted vials over consecutive days. Key comparison:
| Diluent | Preservative | Multi-draw safe? | Stability window (2-8°C) |
|---|---|---|---|
| Sterile water for injection (SWFI) | None | Single-use only | 24 hours |
| Bacteriostatic water (BAC water) | 0.9% benzyl alcohol | Yes, multi-draw | Up to 14 days |
| Normal saline (0.9% NaCl, sterile) | None (multi-dose vials vary) | Limited | 24-48 hours single-use |
Conclusion: always use bacteriostatic water for tesamorelin reconstitution if the protocol spans more than one draw from a vial. REVIVE LAB UAE stocks 30mL BAC water vials specifically sized for multi-week research use.
A tesamorelin 5mg vial contains 5,000mcg of lyophilized peptide. The concentration after reconstitution is simply: Concentration (mg/mL) = 5mg ÷ volume of BAC water added (mL). Research-context dosing from the pivotal Falutz 2007 NEJM trial and the 2010 26-week extension was 2mg/day SC, which produced a 15-18% reduction in visceral adipose tissue (VAT) and approximately 50% elevation in IGF-1 versus placebo. The Stanley 2014 JAMA NAFLD trial used the same 2mg/day SC reference. A more conservative 1mg/day context is also referenced in the literature.
| BAC Water Added | Concentration | 1mg draw (U-100 syringe) | 2mg draw (U-100 syringe) | Vial yields (1mg/day) |
|---|---|---|---|---|
| 1 mL | 5 mg/mL (5,000 mcg/mL) | 20 units (0.20 mL) | 40 units (0.40 mL) | 5 draws |
| 2 mL | 2.5 mg/mL (2,500 mcg/mL) | 40 units (0.40 mL) | 80 units (0.80 mL) | 5 draws |
| 2.5 mL | 2 mg/mL (2,000 mcg/mL) | 50 units (0.50 mL) | 100 units (1.00 mL) | 5 draws |
| 5 mL | 1 mg/mL (1,000 mcg/mL) | 100 units (1.00 mL) | 200 units (2.00 mL) | 5 draws |
Recommended for 5mg vial: 2.5mL BAC water gives exactly 2mg/mL — matching the Falutz trial concentration to the cleanest draw number (50 units for 1mg, 100 units for 2mg). No rounding, no mental math mid-draw.
A tesamorelin 10mg vial contains 10,000mcg of lyophilized peptide. The 10mg vial is the more economical choice for multi-week research protocols, as it extends the supply without requiring an additional reconstitution event. Concentration formula: Concentration (mg/mL) = 10mg ÷ volume of BAC water added (mL).
| BAC Water Added | Concentration | 1mg draw (U-100 syringe) | 2mg draw (U-100 syringe) | Vial yields (1mg/day) |
|---|---|---|---|---|
| 2 mL | 5 mg/mL (5,000 mcg/mL) | 20 units (0.20 mL) | 40 units (0.40 mL) | 10 draws |
| 4 mL | 2.5 mg/mL (2,500 mcg/mL) | 40 units (0.40 mL) | 80 units (0.80 mL) | 10 draws |
| 5 mL | 2 mg/mL (2,000 mcg/mL) | 50 units (0.50 mL) | 100 units (1.00 mL) | 10 draws |
| 10 mL | 1 mg/mL (1,000 mcg/mL) | 100 units (1.00 mL) | 200 units (2.00 mL) | 10 draws |
Recommended for 10mg vial: 5mL BAC water gives 2mg/mL — again mirroring the Falutz protocol with a 50-unit (0.5mL) draw for 1mg or a 100-unit (1mL) draw for 2mg. At 10 draws per vial, this covers a 5-10 day protocol window comfortably within the 14-day post-reconstitution stability ceiling.
All calculations above use a standard U-100 insulin syringe (100 units = 1mL, so 1 unit = 0.01mL). This is the industry-standard reference syringe for subcutaneous peptide research because it minimizes measurement error at the small volumes involved. Never substitute a 3mL or 5mL syringe for sub-1mL draws — the graduation increments are too coarse.
| U-100 Units | Volume (mL) | mcg at 1mg/mL | mcg at 2mg/mL | mcg at 5mg/mL |
|---|---|---|---|---|
| 10 units | 0.10 mL | 100 mcg | 200 mcg | 500 mcg |
| 20 units | 0.20 mL | 200 mcg | 400 mcg | 1,000 mcg (1mg) |
| 50 units | 0.50 mL | 500 mcg | 1,000 mcg (1mg) | 2,500 mcg (2.5mg) |
| 100 units | 1.00 mL | 1,000 mcg (1mg) | 2,000 mcg (2mg) | 5,000 mcg (5mg) |
The pivotal tesamorelin literature gives investigators two well-characterised reference points. Falutz et al. (2007, NEJM, 412 subjects) administered 2mg/day SC in HIV-associated lipodystrophy. The primary endpoint — visceral adipose tissue reduction — reached 15-18% versus placebo at 26 weeks. IGF-1 increased by approximately 50% from baseline. The 2010 26-week extension study (Falutz et al., J Clin Endocrinol Metab) confirmed durability of the VAT effect.
Stanley et al. (2014, JAMA) then applied the same 2mg/day SC protocol in HIV-associated non-alcoholic fatty liver disease (NAFLD), observing a 32% reduction in hepatic fat fraction versus placebo. Stanley et al. (2019, Lancet HIV) extended this to a 12-month randomised trial, confirming the liver fat signal and the metabolic tolerability of the GHRH analog at 2mg/day.
The 1mg/day context appears in subsequent mechanistic sub-analyses as a lower-dose reference arm. For investigators designing pilot experiments, the 1mg/day figure is the conservative anchor; 2mg/day is the primary published effective dose. REVIVE LAB UAE stocks only 5mg and 10mg vials — both formats support either dosing context without waste across the stability window.
Below is the standard protocol used in research laboratories for lyophilized peptide vials. Tesamorelin is moderately fragile — mechanical agitation (shaking, vortexing) and direct injection of diluent onto the cake both accelerate degradation. Follow the sequence precisely.
This is the question most investigators underestimate. The answer depends entirely on the diluent and storage conditions:
| Condition | Stability Estimate | Notes |
|---|---|---|
| Lyophilized vial at 2-8°C (sealed) | 12-24 months (per lot COA) | Optimal long-term storage |
| Lyophilized vial at room temp (<30°C) | Up to 7 days | Short excursion only — not routine storage |
| Reconstituted in BAC water, 2-8°C | Up to 14 days | Benzyl alcohol extends multi-draw window |
| Reconstituted in sterile water, 2-8°C | 24 hours (single use) | No preservative — do not multi-draw |
| Reconstituted vial at room temp (>20°C) | <4 hours | Discard; do not use |
| Reconstituted vial, frozen | Avoid | Freeze-thaw cycles fragment the peptide |
The practical implication for a 5mg vial at 2mg/mL (recommended dilution above): the vial yields five 1mg draws. At one draw per day, the vial is exhausted on day 5 — well inside the 14-day window. At the 2mg/day Falutz protocol rate, it is exhausted on day 2 or 3. Either way, the stability window is not the bottleneck for standard research protocols. Where it becomes relevant is if an investigator front-loads reconstitution across multiple vials at once — in that case, stagger reconstitution dates by 7-day offsets rather than reconstituting everything at once.
Bacteriostatic water is the preferred diluent for exactly this reason — but note that 0.9% benzyl alcohol has its own small impact on peptide solubility at very high concentrations. For tesamorelin at the volumes used in research (typically 1-10 mL BAC water per 5-10mg vial), this effect is negligible. The stability benefit far outweighs any theoretical solubility concern at standard research concentrations.
The reconstitution math only works if the vial contains what the label says. A 5mg vial that is actually 4.2mg due to poor lyophilization or storage failures will cause every subsequent calculation to be systematically wrong — and the investigator will have no way to detect it without a COA and HPLC data. This is why the source matters as much as the protocol.
REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched tesamorelin across all 7 emirates. Every batch is tested for purity ≥99% and correct molecular weight before dispatch. Vials ship in validated cold-chain insulation that holds 2-8°C through UAE summer transit — the same thermal window the Falutz and Stanley trials mandated for investigational product. Whether you want to buy tesamorelin UAE for a pilot lipodystrophy experiment or a longer NAFLD-adjacent protocol, the 5mg and 10mg formats are stocked and ready to dispatch. Payment options include cash on delivery across the UAE and USDT TRC20 via Binance Pay (with a 5% pre-pay discount, transaction ID confirmed via WhatsApp).
| Emirate / City | Delivery Window | Cash on Delivery | Cold-Chain Packaging |
|---|---|---|---|
| Dubai (Marina, JBR, Business Bay, JVC, DIFC, Downtown, Palm, Jumeirah) | Same-day, 4-8 hours | Yes | Yes |
| Abu Dhabi (Corniche, Yas, Saadiyat, Reem) | Next-day, 18-24 hours | Yes | Yes |
| Sharjah | Same-day / next-day, 8-18 hours | Yes | Yes |
| Ajman, RAK, UAQ | Next-day, 18-24 hours | Yes | Yes |
| Fujairah, Al Ain | Next-day, 24 hours | Yes | Yes |
Tesamorelin same day Dubai orders placed before the daily dispatch cut-off arrive cold within hours — Dubai Marina, Business Bay, JVC, Jumeirah, DIFC, Palm Jumeirah and Downtown are all inside the same-day window. For Abu Dhabi, Sharjah and the northern emirates, tesamorelin Dubai 24h delivery is the standard. This is what peptides UAE supply infrastructure looks like when the supplier is genuinely UAE-based, not drop-shipping from overseas.
For the cleanest math, add 2.5mL of bacteriostatic water to a 5mg vial. This gives a concentration of 2mg/mL. At 2mg/mL, a 1mg research-context draw is 50 units (0.5mL) on a U-100 syringe — a precise, unambiguous number that leaves no room for decimal rounding mid-draw. Alternatively, 5mL of BAC water gives 1mg/mL, where 1mg equals exactly 100 units (1mL). Both are clean options; choose based on your preferred draw volume.
Reconstituted tesamorelin stored in bacteriostatic water at 2-8°C is generally stable for up to 14 days. The 0.9% benzyl alcohol in BAC water prevents microbial growth and extends the multi-draw window well beyond plain sterile water (which is single-use, 24-hour stability). Keep the vial protected from light, never freeze it, and label it with the reconstitution date at the time of mixing. REVIVE LAB UAE recommends the same storage parameters applied in the Falutz 2007 and Stanley 2014 trial protocols.
Yes. REVIVE LAB UAE supplies HPLC-verified tesamorelin 5mg and 10mg vials with same-day delivery inside Dubai and tesamorelin 24h delivery across all seven emirates. Cash on delivery is available throughout the UAE. USDT TRC20 via Binance Pay is also accepted with a 5% pre-pay discount — send your transaction ID via WhatsApp to confirm. All orders ship in cold-chain insulated outer packaging, with lot-COA available on request. Search "tesamorelin in stock UAE" and you will find REVIVE LAB UAE at the top for good reason.